273 related articles for article (PubMed ID: 29700923)
1. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis.
Du LP; Cheng ZW; Zhang YX; Li Y; Mei D
J Clin Hypertens (Greenwich); 2018 May; 20(5):902-907. PubMed ID: 29700923
[TBL] [Abstract][Full Text] [Related]
2. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan.
Wang X; Chen H; Essien E; Wu J; Serna O; Paranjpe R; Abughosh S
J Manag Care Spec Pharm; 2019 Jun; 25(6):678-686. PubMed ID: 31134857
[TBL] [Abstract][Full Text] [Related]
3. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study.
Verma AA; Khuu W; Tadrous M; Gomes T; Mamdani MM
PLoS Med; 2018 Jun; 15(6):e1002584. PubMed ID: 29889841
[TBL] [Abstract][Full Text] [Related]
4. Modifications in drug adherence after switch to fixed-dose combination of perindopril/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study.
Degli Esposti L; Perrone V; Veronesi C; Gambera M; Nati G; Perone F; Tagliabue PF; Buda S; Borghi C
Curr Med Res Opin; 2018 Sep; 34(9):1571-1577. PubMed ID: 29376432
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in hypertensive patients treated with a single-pill fixed-dose combination of renin-angiotensin system inhibitor and thiazide diuretic.
Ho CT; Tung YC; Chou SH; Hsiao FC; Lin YS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1731-1738. PubMed ID: 30375168
[TBL] [Abstract][Full Text] [Related]
6. Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?
Bartlett LE; Pratt N; Roughead EE
Curr Med Res Opin; 2018 Feb; 34(2):305-311. PubMed ID: 28945105
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database.
Ishida T; Oh A; Hiroi S; Shimasaki Y; Nishigaki N; Tsuchihashi T
Hypertens Res; 2019 Feb; 42(2):249-256. PubMed ID: 30443023
[TBL] [Abstract][Full Text] [Related]
8. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.
Lauffenburger JC; Landon JE; Fischer MA
J Gen Intern Med; 2017 Jun; 32(6):619-625. PubMed ID: 28050754
[TBL] [Abstract][Full Text] [Related]
9. [Medication adherence with the fixed combination of ramipril and amlodipine].
Simonyi G; Ferenci T
Orv Hetil; 2014 Nov; 155(47):1882-8. PubMed ID: 25403283
[TBL] [Abstract][Full Text] [Related]
10. Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.
Han S; Iglay K; Davies MJ; Zhang Q; Radican L
Curr Med Res Opin; 2012 Jun; 28(6):969-77. PubMed ID: 22494018
[TBL] [Abstract][Full Text] [Related]
11. [Ramipril plus amlodipine and lisinopril plus amlodipine fixed dose combinations and patient's adherence].
Simonyi G; Ferenci T
Orv Hetil; 2016 Jan; 157(1):30-4. PubMed ID: 26708684
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020.
Derington CG; Bress AP; Herrick JS; Jacobs JA; Zheutlin AR; Berchie RO; Conroy MB; Cushman WC; King JB
J Am Heart Assoc; 2023 Jun; 12(11):e028573. PubMed ID: 37158068
[TBL] [Abstract][Full Text] [Related]
13. Adherence and medication utilisation patterns of fixed-dose and free combination of angiotensin receptor blocker/thiazide diuretics among newly diagnosed hypertensive patients: a population-based cohort study.
Hsu CI; Hsiao FY; Wu FL; Shen LJ
Int J Clin Pract; 2015 Jul; 69(7):729-37. PubMed ID: 25395349
[TBL] [Abstract][Full Text] [Related]
14. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
[TBL] [Abstract][Full Text] [Related]
15. Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.
Parati G; Kjeldsen S; Coca A; Cushman WC; Wang J
Hypertension; 2021 Feb; 77(2):692-705. PubMed ID: 33390044
[TBL] [Abstract][Full Text] [Related]
16. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence.
Sherrill B; Halpern M; Khan S; Zhang J; Panjabi S
J Clin Hypertens (Greenwich); 2011 Dec; 13(12):898-909. PubMed ID: 22142349
[TBL] [Abstract][Full Text] [Related]
17. Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?
Bartlett LE; Pratt N; Roughead EE
Br J Clin Pharmacol; 2017 Jan; 83(1):202-210. PubMed ID: 27517705
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
Gadzhanova S; Roughead EE; Bartlett LE
Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
[TBL] [Abstract][Full Text] [Related]
19. Benefits of a fixed-dose combination of bisoprolol and amlodipine in the treatment of hypertension in daily practice: results of more than 4000 patients.
Czarnecka D; Koch EM; Gottwald-Hostalek U
Curr Med Res Opin; 2015 May; 31(5):875-81. PubMed ID: 25753136
[TBL] [Abstract][Full Text] [Related]
20. Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.
Tung YC; Huang YC; Wu LS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2017 Oct; 19(10):983-989. PubMed ID: 28560786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
